"It turns your world upside down, there's no doubt," Bob said.
Concerns about Victoria's health began as far back as 2016. Doctors initially thought she had diverticulitis.
In March of 2017, Bob, on the road with the Wild in Chicago, went home as the team went on to Washington so he could be there as doctors investigated a spot on one of his wife's lungs. Initially, the nodule came back as benign.
But 10 weeks later, when blood showed up in her urine, it was obvious something more sinister had its grips on her. A scan of Victoria's kidney revealed the spot on her lungs was still there. Doctors then did a needle biopsy, and tests on the spot came back as malignant.
And because it was deemed that the cancer had started in her ureter and spread to her lungs, she was told her battle would be a fierce one.
"I couldn't do anything for two or three weeks. Couldn't talk about it. Just totally devastating," Bob said. "When it was going into oncology, going in for chemo treatment was scary as hell, going in there and looking at the seats and the bags and drips and all that. And when we first went in there, it was just like, 'Are you kidding me? We're doing this?' And now it's kind of a new normal for us. It's not a scary place anymore, it's kind of a nice place; we know a lot of people in there and we know the staff.
"It's more of a comforting spot now. But when you first walk in there, it's like looking at death."
Victoria underwent rigorous chemotherapy for 14 months, which shrank some of the spots in her body. In late August, she began treatments of an immunotherapy drug called Keytruda.
The first post-Keytruda scans came back last week, and while the spots hadn't shrunk further, they hadn't increased much in size, either.
The hope is that continued treatments will start moving the ball in the right direction in that regard.
"She's a trouper," Bob said. "A lot of those chemo days, you don't have energy. You're socked, you don't have energy to even get out of bed."